Key Highlights
- World Health Organization has classified NB.1.8.1, also known as Nimbus, as a variant under surveillance due to its rapid global dissemination.
- Patients report an exceptionally painful sore throat, dubbed “razor blade throat,” which sets Nimbus apart from other Omicron descendants.
- Between April 21 and 27 2025, sequencing data show that Nimbus accounted for roughly 10.7 % of all new COVID‑19 samples in 22 countries.
- No significant rise in hospital admissions or fatalities has been linked to Nimbus, and existing vaccines continue to offer protection.
- In parallel, a related subvariant XFG (Stratus) is spreading, though it has yet to be placed under WHO monitoring.
Detailed Insights
The first cases of NB.1.8.1 were reported in January 2025, positioning it as a recent offshoot of the Omicron lineage. The variant’s main clinical feature is the intense, “razor blade” sensation in the throat, often accompanied by the classic Omicron symptoms of cough, fever, and fatigue. Despite its high transmissibility, surveillance data indicate that the strain does not trigger a disproportionate burden on health‑care systems; hospitalisation and mortality remain comparable to non‑Nimbus variants. Vaccination efficacy is preserved, with contemporary doses still neutralising the virus effectively. Current outbreaks span 13 U.S. states, the United Kingdom, and several Asian nations, totaling 22 countries as of late April. In India, while case numbers have plateaued, authorities remain vigilant, urging testing for severe symptoms in high‑risk cohorts. The subvariant XFG (Stratus) has circulated alongside Nimbus but has not yet met WHO criteria for monitoring.
Key Concepts
- Omicron lineage – The broader family of SARS‑CoV‑2 variants that emerged in late 2021, known for numerous mutations and high transmissibility.
- Variant under monitoring – WHO’s designation for strains that warrant close epidemiological observation but have not yet escalated to a public‑health emergency.
- “Razor blade throat” – A colloquially used descriptor for the excruciating soreness reported in Nimbus infections.
- Subvariant – A genetic derivative within a major variant that may possess distinct transmission or immune‑escape features.
- Surveillance data – Genomic sequencing records that inform public‑health decisions about circulating coronavirus strains.